The biotechnology sector centered around microalgae is experiencing a remarkable surge
in growth. So far, over 300,000 distinct species of microalgae have been meticulously …

Alzheimer's disease (AD) is characterized by the accumulation of misfolded amyloid-beta
and tau proteins. Autophagy acts as a proteostasis process to remove protein clumps …

Background Non-coding RNAs (ncRNA) are a kind of RNA that does not encode protein,
which play an important role in Alzheimer's disease (AD). However, there is a lack of …

Memantine is a noncompetitive moderate‐affinity strong voltage‐dependent N‐methyl‐D‐
aspartate receptor antagonist. It has been used to treat Alzheimer's disease (AD) since …

With increasing aging, dementia is a growing public health concern globally. Patients with
dementia have multiple psychological and behavioral changes, including depression …

Background Alzheimer's disease (AD) is a progressive neurodegenerative disorder
characterized by cognitive and behavioral decline. Acrolein, an environmental pollutant and …

This review rigorously investigates the early cerebral changes associated with Alzheimer's
disease, which manifest long before clinical symptoms arise. It presents evidence that the …

New “omic” technologies are revealing shared and distinct biological pathways within and
across neurodegenerative diseases (NDDs), allowing a better understanding of …

Fibril formation by amyloidogenic proteins and peptides is considered the cause of a
number of incurable diseases. One of the most known amyloid diseases is Alzheimer's …

A novel series of benzo [cd] indol-2 (1H)-one-donepezil (BIO-DPZ) hybrids (5a-m, 6a-k) was
designed, synthesized and evaluated as cholinesterase inhibitors and living cell imaging …